(Q38063744)

28 August 2017

1 reference

title

The anti-cancer activities of jasmonates (English)

1 reference

28 August 2017

Ziv Raviv

1

1 reference

28 August 2017

Sharon Cohen

series ordinal

2

1 reference

28 August 2017

Dortit Reischer-Pelech

series ordinal

3

1 reference

28 August 2017

publication date

30 November 2012

1 reference

Cancer Chemotherapy and Pharmacology

28 August 2017

published in

1 reference

28 August 2017

volume

71

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

275-285

1 reference

BIOSYNTHESIS AND ACTION OF JASMONATES IN PLANTS

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Jasmonates: an update on biosynthesis, signal transduction and action in plant stress response, growth and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Fine-Tuning Plant Defence Signalling: Salicylate versus Jasmonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Jasmonate signaling in plant interactions with resistance-inducing beneficial microbes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Regulation of jasmonate-mediated plant responses in arabidopsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Jasmonate- and salicylate-mediated plant defense responses to insect herbivores, pathogens and parasitic plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Interplant communication: airborne methyl jasmonate induces synthesis of proteinase inhibitors in plant leaves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Methyl jasmonate induces production of reactive oxygen species and alterations in mitochondrial dynamics that precede photosynthetic dysfunction and subsequent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Jasmonates in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Methyl jasmonate: a plant stress hormone as an anti-cancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Jasmonates--a new family of anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Jasmonates induce apoptosis and cell cycle arrest in non-small cell lung cancer lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Delayed cytotoxic effects of methyl jasmonate and cis-jasmone induced apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Natural jasmonates of different structures suppress the growth of human neuroblastoma cell line SH-SY5Y and its mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Methyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Mitochondria: releasing power for life and unleashing the machineries of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Oncogenic alterations of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Mitochondrial Membrane Potential in Living Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

The cancer cell's "power plants" as promising therapeutic targets: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

The Warburg effect and mitochondrial stability in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Chemotherapy: targeting the mitochondrial cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Methyl jasmonate binds to and detaches mitochondria-bound hexokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Disruption of the hexokinase-VDAC complex for tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

PI3K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

PI3K pathway alterations in cancer: variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Targeting the phosphoinositide 3-kinase pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Activation of the PI3K/Akt pathway and chemotherapeutic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Steroid hormone transforming aldo-keto reductases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

A methyl jasmonate derivative, J-7, induces apoptosis in human hepatocarcinoma Hep3B cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

J7, a methyl jasmonate derivative, enhances TRAIL-mediated apoptosis through up-regulation of reactive oxygen species generation in human hepatoma HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

The promise of TRAIL--potential and risks of a novel anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

The TRAIL apoptotic pathway in cancer onset, progression and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Anti-inflammatory constituents of the red alga Gracilaria verrucosa and their synthetic analogues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

New jasmonate analogues as potential anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

Anti-inflammatory effect of methyl dehydrojasmonate (J2) is mediated by the NF-κB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

In vivo anti-angiogenic effects further support the promise of the antineoplasic activity of methyl jasmonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2039-Z

10.1007/S00280-012-2039-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1025325889

0 references

1 reference